F&O;: Market setup shaky; don't get carried away by bounce
A good amount of long buildup was seen in Cadila Healthcare , Torrent Pharma and STFC.08-04-2020
08-04-2020
India growth crucial for Torrent Pharma's health amid steep fall in volume
The country accounts for 44% of overall revenues07-04-2020
Torrent Pharma says promoters haven't pledged shares
The promoters are obligated to hold a minimum 26 per cent shares and management control of Torrent Pharma during the period of loans the company has taken, it said.05-04-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Clarification
Please find attached herewith the clarification04-04-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Intimation Regarding Payment Status Of Interim Dividend 2019-20
Please find attached the intimation regarding payment status of Interim Dividend 2019-2002-04-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for issue of duplicate share certificates26-03-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Redemption Of Non-Convertible Debentures
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures (NCDs) of Rs 240 crores (Rupees Two Hundred Forty Crores) issued under ISIN: INE685A07058 has been fully redeemed and repaid by the Company on 24-Mar-20. Kindly take note of the above24-03-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Closure of Trading Window
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading window for dealing in securities of the Company by Designated Persons stands closed from 1st April, 2020 and will be re-opened 48 hours after the submission of the Audited Financial Results for the Financial Year ended 31st March, 2020 to the Stock Exchanges.20-03-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Issue of Duplicate Share Certificate12-03-2020
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend
We would like to inform that the Board has at its meeting held today approved an interim dividend of Rs 32/- (640%) per equity share of Rs 5/- fully paid up. This includes a special dividend of Rs 15/- per equity share, in view of the successful integration of the acquired business. The integration has complemented in enhancing the overall performance of the Company. The dividend is expected to be paid / dispatched on or around 26th March, 2020.11-03-2020